| 0 |
KOEPPE NODULES |
2 |
0.2500 |
| 1 |
BEHAVIOUR DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0714 |
| 2 |
CAMPYLOBACTER BACTERAEMIA |
2 |
0.0667 |
| 3 |
ALLERGIC BRONCHOPULMONARY MYCOSIS |
1 |
0.0588 |
| 4 |
BLOOD BETA-D-GLUCAN POSITIVE |
1 |
0.0385 |
| 5 |
CAMPYLOBACTER COLITIS |
3 |
0.0349 |
| 6 |
MYOCARDITIS BACTERIAL |
1 |
0.0303 |
| 7 |
TRIGEMINAL PALSY |
1 |
0.0217 |
| 8 |
BACTERIAL DIARRHOEA |
4 |
0.0190 |
| 9 |
LUMBOSACRAL RADICULOPATHY |
3 |
0.0186 |
| 10 |
IMMUNOTOXICITY |
2 |
0.0175 |
| 11 |
PLASMA CELL MYELOMA REFRACTORY |
20 |
0.0149 |
| 12 |
NAIL DEFORMATION |
1 |
0.0149 |
| 13 |
PEDAL PULSE DECREASED |
1 |
0.0147 |
| 14 |
LIGHT CHAIN ANALYSIS DECREASED |
1 |
0.0145 |
| 15 |
ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0139 |
| 16 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
57 |
0.0129 |
| 17 |
EAR, NOSE AND THROAT INFECTION |
1 |
0.0122 |
| 18 |
PUNCTURE SITE ERYTHEMA |
1 |
0.0116 |
| 19 |
B-CELL LYMPHOMA REFRACTORY |
1 |
0.0112 |
| 20 |
VIRAL UVEITIS |
1 |
0.0103 |
| 21 |
CYTOKINE RELEASE SYNDROME |
207 |
0.0103 |
| 22 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
60 |
0.0101 |
| 23 |
ADENOVIRAL HEPATITIS |
2 |
0.0085 |
| 24 |
ACHROMOBACTER INFECTION |
1 |
0.0083 |
| 25 |
HUMAN RHINOVIRUS TEST POSITIVE |
3 |
0.0080 |
| 26 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
6 |
0.0078 |
| 27 |
IMMUNOGLOBULINS ABNORMAL |
2 |
0.0077 |
| 28 |
HERPES ZOSTER REACTIVATION |
2 |
0.0076 |
| 29 |
ENCEPHALITIS CYTOMEGALOVIRUS |
3 |
0.0068 |
| 30 |
IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME |
1 |
0.0066 |
| 31 |
PARAPROTEINAEMIA |
2 |
0.0065 |
| 32 |
VARICELLA ZOSTER PNEUMONIA |
1 |
0.0057 |
| 33 |
MENINGOENCEPHALITIS VIRAL |
1 |
0.0056 |
| 34 |
LARYNGEAL OBSTRUCTION |
1 |
0.0055 |
| 35 |
HUMORAL IMMUNE DEFECT |
2 |
0.0054 |
| 36 |
CYTOMEGALOVIRUS CHORIORETINITIS |
10 |
0.0051 |
| 37 |
SUSPECTED OFF LABEL USE |
23 |
0.0051 |
| 38 |
HANGING |
1 |
0.0051 |
| 39 |
SALMONELLA BACTERAEMIA |
1 |
0.0048 |
| 40 |
LIGHT CHAIN ANALYSIS ABNORMAL |
1 |
0.0048 |
| 41 |
IMMOBILISATION SYNDROME |
1 |
0.0047 |
| 42 |
CYTOMEGALOVIRUS GASTROENTERITIS |
1 |
0.0046 |
| 43 |
CARDIOMYOPATHY ACUTE |
1 |
0.0046 |
| 44 |
TUMOUR PSEUDOPROGRESSION |
5 |
0.0046 |
| 45 |
EPIDERMOLYSIS |
2 |
0.0043 |
| 46 |
PERIPHERAL VEIN THROMBOSIS |
1 |
0.0042 |
| 47 |
UPPER RESPIRATORY TRACT INFLAMMATION |
5 |
0.0042 |
| 48 |
HYPOGAMMAGLOBULINAEMIA |
26 |
0.0040 |
| 49 |
NEUTROPHIL PERCENTAGE DECREASED |
2 |
0.0038 |
| 50 |
EOSINOPHIL PERCENTAGE INCREASED |
2 |
0.0037 |
| 51 |
HYPERCALCAEMIA OF MALIGNANCY |
1 |
0.0037 |
| 52 |
CUTIS LAXA |
1 |
0.0037 |
| 53 |
INTERLEUKIN LEVEL INCREASED |
2 |
0.0036 |
| 54 |
MONOCLONAL IMMUNOGLOBULIN INCREASED |
1 |
0.0035 |
| 55 |
GALLBLADDER OEDEMA |
1 |
0.0034 |
| 56 |
CAMPYLOBACTER GASTROENTERITIS |
2 |
0.0034 |
| 57 |
BLOOD BETA-D-GLUCAN INCREASED |
1 |
0.0033 |
| 58 |
ANOREXIA NERVOSA |
1 |
0.0031 |
| 59 |
GASTRIC VARICES HAEMORRHAGE |
1 |
0.0030 |
| 60 |
LIGHT CHAIN ANALYSIS INCREASED |
3 |
0.0029 |
| 61 |
BLOOD IMMUNOGLOBULIN G DECREASED |
7 |
0.0028 |
| 62 |
MONOCYTE PERCENTAGE INCREASED |
2 |
0.0028 |
| 63 |
DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION |
1 |
0.0028 |
| 64 |
CYTOMEGALOVIRUS VIRAEMIA |
12 |
0.0027 |
| 65 |
CONJUNCTIVAL DISORDER |
1 |
0.0026 |
| 66 |
CYSTITIS VIRAL |
1 |
0.0026 |
| 67 |
BONE MARROW INFILTRATION |
1 |
0.0026 |
| 68 |
PNEUMONIA CYTOMEGALOVIRAL |
5 |
0.0026 |
| 69 |
SUPERINFECTION BACTERIAL |
2 |
0.0025 |
| 70 |
PNEUMONIA INFLUENZAL |
3 |
0.0025 |
| 71 |
HERPES ZOSTER DISSEMINATED |
2 |
0.0025 |
| 72 |
NORMAL PRESSURE HYDROCEPHALUS |
1 |
0.0024 |
| 73 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
2 |
0.0024 |
| 74 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 75 |
ENTEROVIRUS INFECTION |
2 |
0.0023 |
| 76 |
CYTOMEGALOVIRUS TEST POSITIVE |
4 |
0.0022 |
| 77 |
IMMUNOGLOBULINS DECREASED |
3 |
0.0022 |
| 78 |
GASTRITIS BACTERIAL |
1 |
0.0021 |
| 79 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
0.0021 |
| 80 |
ECZEMA ASTEATOTIC |
1 |
0.0021 |
| 81 |
BLAST CELLS PRESENT |
1 |
0.0021 |
| 82 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
17 |
0.0021 |
| 83 |
IMMUNE-MEDIATED THYROIDITIS |
1 |
0.0020 |
| 84 |
METASTASES TO BONE MARROW |
1 |
0.0020 |
| 85 |
HERPES ZOSTER OTICUS |
1 |
0.0020 |
| 86 |
ORTHOPAEDIC PROCEDURE |
1 |
0.0019 |
| 87 |
PERTUSSIS |
2 |
0.0019 |
| 88 |
HEPATITIS B REACTIVATION |
6 |
0.0019 |
| 89 |
EYE INFECTION BACTERIAL |
1 |
0.0018 |
| 90 |
T-CELL LYMPHOMA |
2 |
0.0017 |
| 91 |
OPHTHALMIC HERPES SIMPLEX |
1 |
0.0017 |
| 92 |
HAEMATOMA INFECTION |
1 |
0.0017 |
| 93 |
CYTOMEGALOVIRUS INFECTION |
28 |
0.0017 |
| 94 |
SECOND PRIMARY MALIGNANCY |
14 |
0.0017 |
| 95 |
ESCHERICHIA TEST POSITIVE |
2 |
0.0017 |
| 96 |
PLASMA CELL LEUKAEMIA |
1 |
0.0017 |
| 97 |
ENCEPHALITIS VIRAL |
2 |
0.0016 |
| 98 |
MUSCLE ABSCESS |
1 |
0.0016 |
| 99 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 100 |
GLIOMA |
1 |
0.0016 |
| 101 |
PHYSICAL DECONDITIONING |
4 |
0.0016 |
| 102 |
BLOOD IMMUNOGLOBULIN A DECREASED |
1 |
0.0015 |
| 103 |
KLEBSIELLA TEST POSITIVE |
1 |
0.0015 |
| 104 |
CYTOPENIA |
18 |
0.0015 |
| 105 |
TUMOUR FLARE |
1 |
0.0015 |
| 106 |
CENTRAL SEROUS CHORIORETINOPATHY |
1 |
0.0015 |
| 107 |
INJECTION SITE MACULE |
1 |
0.0015 |
| 108 |
FACIAL DISCOMFORT |
1 |
0.0014 |
| 109 |
VIRAL HAEMORRHAGIC CYSTITIS |
1 |
0.0014 |
| 110 |
PALMOPLANTAR KERATODERMA |
1 |
0.0014 |
| 111 |
BACTERIAL DISEASE CARRIER |
1 |
0.0014 |
| 112 |
CHOLANGITIS ACUTE |
1 |
0.0013 |
| 113 |
BRONCHITIS BACTERIAL |
1 |
0.0013 |
| 114 |
PNEUMONIA PSEUDOMONAL |
2 |
0.0013 |
| 115 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 116 |
EYELID FUNCTION DISORDER |
1 |
0.0013 |
| 117 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 118 |
VARICELLA |
3 |
0.0013 |
| 119 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 120 |
PERONEAL NERVE PALSY |
7 |
0.0012 |
| 121 |
ANAL ULCER |
1 |
0.0012 |
| 122 |
PSEUDOMONAS TEST POSITIVE |
1 |
0.0012 |
| 123 |
HYPOPYON |
1 |
0.0012 |
| 124 |
CAMPYLOBACTER INFECTION |
1 |
0.0012 |
| 125 |
GASTROENTERITIS SALMONELLA |
1 |
0.0012 |
| 126 |
HYPERPYREXIA |
5 |
0.0012 |
| 127 |
CRANIOFACIAL FRACTURE |
1 |
0.0012 |
| 128 |
PLASMA CELL MYELOMA |
45 |
0.0012 |
| 129 |
AXONAL NEUROPATHY |
1 |
0.0011 |
| 130 |
PSEUDOMONAL SEPSIS |
2 |
0.0011 |
| 131 |
INJECTION SITE DRYNESS |
1 |
0.0011 |
| 132 |
OROPHARYNGEAL CANDIDIASIS |
1 |
0.0011 |
| 133 |
TRAUMATIC INTRACRANIAL HAEMORRHAGE |
1 |
0.0011 |
| 134 |
ADENOCARCINOMA GASTRIC |
1 |
0.0011 |
| 135 |
PLASMACYTOMA |
2 |
0.0011 |
| 136 |
CEREBRAL TOXOPLASMOSIS |
1 |
0.0011 |
| 137 |
PERFORMANCE STATUS DECREASED |
5 |
0.0011 |
| 138 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 139 |
RHINOVIRUS INFECTION |
4 |
0.0010 |
| 140 |
MASTOIDITIS |
1 |
0.0010 |
| 141 |
DROWNING |
1 |
0.0010 |
| 142 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 143 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 144 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 145 |
INNER EAR DISORDER |
1 |
0.0009 |
| 146 |
PRODUCT SELECTION ERROR |
1 |
0.0009 |
| 147 |
OCULAR TOXICITY |
1 |
0.0009 |
| 148 |
ESSENTIAL TREMOR |
1 |
0.0009 |
| 149 |
VITH NERVE PARALYSIS |
1 |
0.0009 |
| 150 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 151 |
INFECTION REACTIVATION |
1 |
0.0009 |
| 152 |
CYTOMEGALOVIRUS COLITIS |
2 |
0.0009 |
| 153 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
1 |
0.0009 |
| 154 |
SYSTEMIC MYCOSIS |
1 |
0.0009 |
| 155 |
LIP ULCERATION |
1 |
0.0009 |
| 156 |
PROCALCITONIN INCREASED |
1 |
0.0009 |
| 157 |
FEBRILE INFECTION |
1 |
0.0008 |
| 158 |
MALIGNANT NEOPLASM PROGRESSION |
87 |
0.0008 |
| 159 |
RETINAL VASCULITIS |
1 |
0.0008 |
| 160 |
RECTAL PROLAPSE |
1 |
0.0008 |
| 161 |
CLOSTRIDIUM COLITIS |
1 |
0.0008 |
| 162 |
UVEITIS |
11 |
0.0008 |
| 163 |
XEROSIS |
1 |
0.0008 |
| 164 |
INTRA-ABDOMINAL HAEMATOMA |
1 |
0.0008 |
| 165 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
1 |
0.0008 |
| 166 |
PROTEIN TOTAL DECREASED |
3 |
0.0008 |
| 167 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
1 |
0.0008 |
| 168 |
TUMOUR LYSIS SYNDROME |
7 |
0.0008 |
| 169 |
NEUTROPHIL PERCENTAGE INCREASED |
1 |
0.0008 |
| 170 |
RETINAL ARTERY OCCLUSION |
2 |
0.0008 |
| 171 |
PLATELET TRANSFUSION |
1 |
0.0008 |
| 172 |
NAIL DISCOLOURATION |
3 |
0.0008 |
| 173 |
PNEUMONIA FUNGAL |
3 |
0.0008 |
| 174 |
HERPES OPHTHALMIC |
1 |
0.0008 |
| 175 |
CORONAVIRUS INFECTION |
5 |
0.0008 |
| 176 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 177 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 178 |
MENINGITIS VIRAL |
1 |
0.0007 |
| 179 |
PERIPHERAL ARTERY THROMBOSIS |
1 |
0.0007 |
| 180 |
PRERENAL FAILURE |
1 |
0.0007 |
| 181 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 182 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 183 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
1 |
0.0007 |
| 184 |
NEOPLASM PROGRESSION |
24 |
0.0007 |
| 185 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 186 |
ADENOVIRUS INFECTION |
2 |
0.0007 |
| 187 |
NEUROTOXICITY |
12 |
0.0007 |
| 188 |
CONJUNCTIVITIS ALLERGIC |
1 |
0.0007 |
| 189 |
INFUSION SITE REACTION |
2 |
0.0007 |
| 190 |
GASTRITIS HAEMORRHAGIC |
1 |
0.0007 |
| 191 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 192 |
GASTROSTOMY |
1 |
0.0006 |
| 193 |
FULL BLOOD COUNT DECREASED |
13 |
0.0006 |
| 194 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 195 |
BILE DUCT STONE |
2 |
0.0006 |
| 196 |
PNEUMONIA VIRAL |
2 |
0.0006 |
| 197 |
PAPILLOMA VIRAL INFECTION |
1 |
0.0006 |
| 198 |
OTITIS MEDIA |
2 |
0.0006 |
| 199 |
ORGANISING PNEUMONIA |
3 |
0.0006 |
| 200 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 201 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
1 |
0.0006 |
| 202 |
SALMONELLOSIS |
1 |
0.0006 |
| 203 |
NEOPLASM RECURRENCE |
2 |
0.0006 |
| 204 |
PSEUDOMONAS INFECTION |
5 |
0.0006 |
| 205 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 206 |
RETINITIS |
1 |
0.0006 |
| 207 |
BLOOD CREATININE ABNORMAL |
2 |
0.0006 |
| 208 |
DERMATITIS EXFOLIATIVE GENERALISED |
2 |
0.0006 |
| 209 |
VASCULAR PSEUDOANEURYSM |
1 |
0.0006 |
| 210 |
NECROTISING FASCIITIS |
2 |
0.0006 |
| 211 |
COMPRESSION FRACTURE |
3 |
0.0006 |
| 212 |
VOCAL CORD PARALYSIS |
1 |
0.0006 |
| 213 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 214 |
OPPORTUNISTIC INFECTION |
1 |
0.0005 |
| 215 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 216 |
INJECTION SITE CELLULITIS |
1 |
0.0005 |
| 217 |
ACCIDENTAL DEATH |
1 |
0.0005 |
| 218 |
LEUKOENCEPHALOPATHY |
2 |
0.0005 |
| 219 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 220 |
SKIN TOXICITY |
3 |
0.0005 |
| 221 |
DIPLEGIA |
1 |
0.0005 |
| 222 |
ORGAN FAILURE |
2 |
0.0005 |
| 223 |
PERIPHERAL ISCHAEMIA |
2 |
0.0005 |
| 224 |
CHOLANGITIS SCLEROSING |
1 |
0.0005 |
| 225 |
CHEST INJURY |
1 |
0.0005 |
| 226 |
RED CELL DISTRIBUTION WIDTH INCREASED |
2 |
0.0005 |
| 227 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
1 |
0.0005 |
| 228 |
FACIAL PARALYSIS |
4 |
0.0005 |
| 229 |
RADIATION PNEUMONITIS |
1 |
0.0005 |
| 230 |
CD4 LYMPHOCYTES DECREASED |
1 |
0.0005 |
| 231 |
ALTERED STATE OF CONSCIOUSNESS |
10 |
0.0005 |
| 232 |
TENDON DISORDER |
3 |
0.0005 |
| 233 |
LARGE INTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 234 |
CALCINOSIS |
1 |
0.0004 |
| 235 |
PNEUMONIA BACTERIAL |
4 |
0.0004 |
| 236 |
BLOOD PRESSURE DIASTOLIC INCREASED |
2 |
0.0004 |
| 237 |
FLAT AFFECT |
1 |
0.0004 |
| 238 |
PATELLA FRACTURE |
1 |
0.0004 |
| 239 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 240 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
1 |
0.0004 |
| 241 |
PUSTULE |
1 |
0.0004 |
| 242 |
NEUTROPHIL COUNT DECREASED |
17 |
0.0004 |
| 243 |
HUMERUS FRACTURE |
2 |
0.0004 |
| 244 |
GUILLAIN-BARRE SYNDROME |
2 |
0.0004 |
| 245 |
C-REACTIVE PROTEIN INCREASED |
15 |
0.0004 |
| 246 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 247 |
EYE OEDEMA |
1 |
0.0004 |
| 248 |
SUFFOCATION FEELING |
1 |
0.0004 |
| 249 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 250 |
DERMATITIS EXFOLIATIVE |
2 |
0.0004 |
| 251 |
TOXIC SKIN ERUPTION |
4 |
0.0004 |
| 252 |
LYMPHOCYTE COUNT DECREASED |
7 |
0.0004 |
| 253 |
HEPATIC CYTOLYSIS |
5 |
0.0004 |
| 254 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 255 |
CANCER PAIN |
1 |
0.0004 |
| 256 |
INJECTION SITE RASH |
12 |
0.0004 |
| 257 |
FEMORAL NECK FRACTURE |
2 |
0.0004 |
| 258 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 259 |
VENTRICULAR DYSFUNCTION |
1 |
0.0004 |
| 260 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 261 |
RADICULOPATHY |
1 |
0.0004 |
| 262 |
LUNG OPACITY |
1 |
0.0004 |
| 263 |
POST PROCEDURAL INFECTION |
3 |
0.0004 |
| 264 |
SEPTIC SHOCK |
16 |
0.0004 |
| 265 |
BLOOD PRESSURE SYSTOLIC INCREASED |
7 |
0.0004 |
| 266 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 267 |
NEUROLOGICAL SYMPTOM |
2 |
0.0003 |
| 268 |
PARAPLEGIA |
1 |
0.0003 |
| 269 |
SKIN WARM |
2 |
0.0003 |
| 270 |
SKIN EXFOLIATION |
29 |
0.0003 |
| 271 |
COVID-19 PNEUMONIA |
4 |
0.0003 |
| 272 |
BACTERAEMIA |
4 |
0.0003 |
| 273 |
HEPATITIS FULMINANT |
1 |
0.0003 |
| 274 |
IMMUNODEFICIENCY |
5 |
0.0003 |
| 275 |
HEPATITIS B |
2 |
0.0003 |
| 276 |
CHOLANGITIS |
2 |
0.0003 |
| 277 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 278 |
BRAIN OEDEMA |
4 |
0.0003 |
| 279 |
INJECTION SITE IRRITATION |
4 |
0.0003 |
| 280 |
PLASMA CELL MYELOMA RECURRENT |
1 |
0.0003 |
| 281 |
HEPATITIS ACUTE |
2 |
0.0003 |
| 282 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 283 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 284 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 285 |
INFECTION |
44 |
0.0003 |
| 286 |
LISTLESS |
1 |
0.0003 |
| 287 |
IMMUNE SYSTEM DISORDER |
4 |
0.0003 |
| 288 |
SKIN INJURY |
1 |
0.0003 |
| 289 |
LYME DISEASE |
1 |
0.0003 |
| 290 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
3 |
0.0003 |
| 291 |
METASTASES TO SPINE |
1 |
0.0003 |
| 292 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 293 |
NEUTROPENIA |
40 |
0.0003 |
| 294 |
NEUTROPHIL COUNT INCREASED |
3 |
0.0003 |
| 295 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 296 |
FACIAL PARESIS |
1 |
0.0003 |
| 297 |
MYELOSUPPRESSION |
10 |
0.0003 |
| 298 |
ANOSMIA |
4 |
0.0003 |
| 299 |
ORAL DISORDER |
2 |
0.0003 |
| 300 |
VIRAL INFECTION |
9 |
0.0003 |
| 301 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 302 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 303 |
APHTHOUS ULCER |
2 |
0.0003 |
| 304 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 305 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 306 |
POLYNEUROPATHY |
3 |
0.0003 |
| 307 |
AZOTAEMIA |
1 |
0.0003 |
| 308 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 309 |
BLEPHARITIS |
1 |
0.0002 |
| 310 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 311 |
RECURRENT CANCER |
1 |
0.0002 |
| 312 |
DEMYELINATION |
1 |
0.0002 |
| 313 |
HYPERURICAEMIA |
1 |
0.0002 |
| 314 |
COAGULOPATHY |
4 |
0.0002 |
| 315 |
PYREXIA |
82 |
0.0002 |
| 316 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 317 |
FEBRILE BONE MARROW APLASIA |
1 |
0.0002 |
| 318 |
SHOULDER OPERATION |
1 |
0.0002 |
| 319 |
HEPATIC FAILURE |
7 |
0.0002 |
| 320 |
PYELONEPHRITIS |
2 |
0.0002 |
| 321 |
DELIRIUM |
8 |
0.0002 |
| 322 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 323 |
HYPOXIA |
8 |
0.0002 |
| 324 |
IMMUNOSUPPRESSION |
2 |
0.0002 |
| 325 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 326 |
NEUROPATHY PERIPHERAL |
21 |
0.0002 |
| 327 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 328 |
UROSEPSIS |
2 |
0.0002 |
| 329 |
HYPOMAGNESAEMIA |
3 |
0.0002 |
| 330 |
SEPSIS |
24 |
0.0002 |
| 331 |
MASS |
3 |
0.0002 |
| 332 |
YELLOW SKIN |
1 |
0.0002 |
| 333 |
FLANK PAIN |
2 |
0.0002 |
| 334 |
DISSEMINATED INTRAVASCULAR COAGULATION |
3 |
0.0002 |
| 335 |
WHITE BLOOD CELL COUNT DECREASED |
23 |
0.0002 |
| 336 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
6 |
0.0002 |
| 337 |
SKIN ABRASION |
1 |
0.0002 |
| 338 |
FEBRILE NEUTROPENIA |
14 |
0.0002 |
| 339 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 340 |
SARCOIDOSIS |
1 |
0.0002 |
| 341 |
SUBDURAL HAEMATOMA |
3 |
0.0002 |
| 342 |
PARKINSONISM |
2 |
0.0002 |
| 343 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 344 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 345 |
PNEUMONIA ASPIRATION |
5 |
0.0002 |
| 346 |
ERYSIPELAS |
1 |
0.0002 |
| 347 |
TOXIC ENCEPHALOPATHY |
1 |
0.0002 |
| 348 |
TASTE DISORDER |
4 |
0.0002 |
| 349 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 350 |
AMMONIA INCREASED |
1 |
0.0002 |
| 351 |
CACHEXIA |
1 |
0.0002 |
| 352 |
VARICOSE VEIN |
1 |
0.0002 |
| 353 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 354 |
BRAIN FOG |
3 |
0.0002 |
| 355 |
POLYARTHRITIS |
1 |
0.0002 |
| 356 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 357 |
SUDDEN DEATH |
2 |
0.0002 |
| 358 |
INFLUENZA |
21 |
0.0002 |
| 359 |
RASH ERYTHEMATOUS |
9 |
0.0002 |
| 360 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 361 |
GINGIVITIS |
1 |
0.0002 |
| 362 |
BLOOD BILIRUBIN INCREASED |
5 |
0.0002 |
| 363 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 364 |
ASPIRATION |
2 |
0.0002 |
| 365 |
PNEUMONIA |
59 |
0.0002 |
| 366 |
GENERAL PHYSICAL HEALTH DETERIORATION |
21 |
0.0002 |
| 367 |
HYPERKERATOSIS |
1 |
0.0002 |
| 368 |
STEVENS-JOHNSON SYNDROME |
4 |
0.0002 |
| 369 |
DEMENTIA |
5 |
0.0002 |
| 370 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 371 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 372 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 373 |
ENTEROCOLITIS |
1 |
0.0002 |
| 374 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 375 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 376 |
BRADYKINESIA |
1 |
0.0002 |
| 377 |
PLEURISY |
1 |
0.0002 |
| 378 |
PRODUCTIVE COUGH |
8 |
0.0002 |
| 379 |
ODYNOPHAGIA |
1 |
0.0002 |
| 380 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
0.0002 |
| 381 |
CHILLS |
19 |
0.0002 |
| 382 |
AGEUSIA |
4 |
0.0002 |
| 383 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 384 |
OXYGEN SATURATION DECREASED |
9 |
0.0002 |
| 385 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 386 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 387 |
HYPOTENSION |
32 |
0.0002 |
| 388 |
SWELLING OF EYELID |
1 |
0.0002 |
| 389 |
CELLULITIS |
8 |
0.0002 |
| 390 |
HYPOCALCAEMIA |
3 |
0.0002 |
| 391 |
FRACTURE |
3 |
0.0002 |
| 392 |
LIVER DISORDER |
7 |
0.0002 |
| 393 |
HERPES ZOSTER |
9 |
0.0002 |
| 394 |
RESPIRATORY TRACT INFECTION |
4 |
0.0002 |
| 395 |
WALKING AID USER |
1 |
0.0002 |
| 396 |
UPPER LIMB FRACTURE |
3 |
0.0002 |
| 397 |
PLATELET COUNT DECREASED |
16 |
0.0001 |
| 398 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 399 |
PNEUMONITIS |
4 |
0.0001 |
| 400 |
APHONIA |
2 |
0.0001 |
| 401 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 402 |
DECREASED APPETITE |
33 |
0.0001 |
| 403 |
ANAEMIA |
27 |
0.0001 |
| 404 |
HAND FRACTURE |
1 |
0.0001 |
| 405 |
LEUKOPENIA |
7 |
0.0001 |
| 406 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 407 |
MYELODYSPLASTIC SYNDROME |
2 |
0.0001 |
| 408 |
SINUSITIS |
14 |
0.0001 |
| 409 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 410 |
SENSITIVE SKIN |
1 |
0.0001 |
| 411 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 412 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 413 |
HEPATOTOXICITY |
3 |
0.0001 |
| 414 |
DEATH |
115 |
0.0001 |
| 415 |
COLITIS |
5 |
0.0001 |
| 416 |
COVID-19 |
23 |
0.0001 |
| 417 |
HYPERTHERMIA |
1 |
0.0001 |
| 418 |
RENAL IMPAIRMENT |
11 |
0.0001 |
| 419 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 420 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 421 |
LYMPHOMA |
2 |
0.0001 |
| 422 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 423 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 424 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
3 |
0.0001 |
| 425 |
HAEMOGLOBIN DECREASED |
13 |
0.0001 |
| 426 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
2 |
0.0001 |
| 427 |
MIOSIS |
1 |
0.0001 |
| 428 |
RHINITIS |
1 |
0.0001 |
| 429 |
RESPIRATORY FAILURE |
9 |
0.0001 |
| 430 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 431 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 432 |
DECUBITUS ULCER |
1 |
0.0001 |
| 433 |
ASPHYXIA |
1 |
0.0001 |
| 434 |
HICCUPS |
1 |
0.0001 |
| 435 |
HYPERAESTHESIA |
1 |
0.0001 |
| 436 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 437 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 438 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 439 |
INJECTION SITE ERYTHEMA |
15 |
0.0001 |
| 440 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 441 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 442 |
MYOPATHY |
1 |
0.0001 |
| 443 |
SKIN SWELLING |
1 |
0.0001 |
| 444 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 445 |
NAIL DISORDER |
1 |
0.0001 |
| 446 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 447 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 448 |
LUNG INFILTRATION |
1 |
0.0001 |
| 449 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 450 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 451 |
CARDIOTOXICITY |
1 |
0.0001 |
| 452 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 453 |
CEREBRAL HAEMORRHAGE |
4 |
0.0001 |
| 454 |
HEART RATE INCREASED |
11 |
0.0001 |
| 455 |
RASH PRURITIC |
6 |
0.0001 |
| 456 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 457 |
NERVE COMPRESSION |
1 |
0.0001 |
| 458 |
THROMBOCYTOPENIA |
12 |
0.0001 |
| 459 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 460 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 461 |
LEUKAEMIA |
1 |
0.0001 |
| 462 |
HAEMATOTOXICITY |
1 |
0.0001 |
| 463 |
GASTRIC ULCER |
2 |
0.0001 |
| 464 |
RED BLOOD CELL COUNT DECREASED |
3 |
0.0001 |
| 465 |
BALANCE DISORDER |
9 |
0.0001 |
| 466 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 467 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 468 |
HERNIA |
2 |
0.0001 |
| 469 |
RASH |
45 |
0.0001 |
| 470 |
BONE PAIN |
6 |
0.0001 |
| 471 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 472 |
DISORIENTATION |
4 |
0.0001 |
| 473 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 474 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 475 |
BRAIN INJURY |
1 |
0.0001 |
| 476 |
CARDIAC FAILURE |
8 |
0.0001 |
| 477 |
DRY MOUTH |
8 |
0.0001 |
| 478 |
EYELID PTOSIS |
1 |
0.0001 |
| 479 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 480 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 481 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 482 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 483 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 484 |
EYE DISCHARGE |
1 |
0.0001 |
| 485 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 486 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 487 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 488 |
JOINT INJURY |
2 |
0.0001 |
| 489 |
LACTIC ACIDOSIS |
3 |
0.0001 |
| 490 |
SKIN LACERATION |
1 |
0.0001 |
| 491 |
BACK INJURY |
1 |
0.0001 |
| 492 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 493 |
BLOOD PRESSURE INCREASED |
14 |
0.0001 |
| 494 |
MELAENA |
2 |
0.0001 |
| 495 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 496 |
SKIN DISORDER |
3 |
0.0001 |
| 497 |
SKIN INFECTION |
1 |
0.0001 |
| 498 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 499 |
EYE INFECTION |
1 |
0.0001 |
| 500 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 501 |
NEOPLASM |
1 |
0.0001 |
| 502 |
SHOCK |
2 |
0.0001 |
| 503 |
HYPOKALAEMIA |
4 |
0.0001 |
| 504 |
EYELID OEDEMA |
1 |
0.0001 |
| 505 |
HEART RATE DECREASED |
3 |
0.0001 |
| 506 |
NASAL CONGESTION |
5 |
0.0001 |
| 507 |
CHOLECYSTITIS |
1 |
0.0001 |
| 508 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 509 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 510 |
ATRIAL FIBRILLATION |
8 |
0.0001 |
| 511 |
LUNG DISORDER |
4 |
0.0001 |
| 512 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 513 |
CARDIOMEGALY |
1 |
0.0001 |
| 514 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 515 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 516 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 517 |
EYE SWELLING |
3 |
0.0001 |
| 518 |
PHARYNGITIS |
1 |
0.0001 |
| 519 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 520 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 521 |
RHINORRHOEA |
5 |
0.0001 |
| 522 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 523 |
DEAFNESS |
2 |
0.0001 |
| 524 |
TOOTH INFECTION |
1 |
0.0001 |
| 525 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 526 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 527 |
PANCREATITIS |
4 |
0.0001 |
| 528 |
ADVERSE REACTION |
1 |
0.0001 |
| 529 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 530 |
DRY SKIN |
10 |
0.0001 |
| 531 |
FATIGUE |
58 |
0.0001 |
| 532 |
LIMB INJURY |
2 |
0.0001 |
| 533 |
BLINDNESS |
3 |
0.0001 |
| 534 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 535 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 536 |
INJECTION SITE REACTION |
5 |
0.0001 |
| 537 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 538 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 539 |
ASTHENIA |
27 |
0.0001 |
| 540 |
HUNGER |
1 |
0.0001 |
| 541 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 542 |
PANCYTOPENIA |
4 |
0.0001 |
| 543 |
HYPERSOMNIA |
2 |
0.0001 |
| 544 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 545 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 546 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 547 |
MENTAL DISORDER |
3 |
0.0001 |
| 548 |
HYPOKINESIA |
1 |
0.0001 |
| 549 |
GASTROENTERITIS |
1 |
0.0001 |
| 550 |
RENAL FAILURE |
9 |
0.0001 |
| 551 |
TACHYCARDIA |
6 |
0.0001 |
| 552 |
PULMONARY MASS |
1 |
0.0001 |
| 553 |
COLON CANCER |
1 |
0.0001 |
| 554 |
PULMONARY OEDEMA |
3 |
0.0001 |
| 555 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 556 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 557 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 558 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 559 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
| 560 |
OEDEMA PERIPHERAL |
8 |
0.0001 |
| 561 |
FEMUR FRACTURE |
2 |
0.0001 |
| 562 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 563 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 564 |
CYANOSIS |
1 |
0.0001 |
| 565 |
COMA |
3 |
0.0001 |
| 566 |
ULCER |
1 |
0.0001 |
| 567 |
SCIATICA |
1 |
0.0001 |
| 568 |
GAIT DISTURBANCE |
12 |
0.0001 |
| 569 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 570 |
HIP FRACTURE |
2 |
0.0001 |
| 571 |
DIARRHOEA |
40 |
0.0001 |
| 572 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 573 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 574 |
DEEP VEIN THROMBOSIS |
4 |
0.0001 |
| 575 |
SWELLING FACE |
4 |
0.0001 |
| 576 |
COUGH |
17 |
0.0001 |
| 577 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 578 |
BACK PAIN |
14 |
0.0001 |
| 579 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 580 |
FUNGAL INFECTION |
2 |
0.0001 |
| 581 |
CANDIDA INFECTION |
1 |
0.0001 |
| 582 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 583 |
URINARY TRACT INFECTION |
10 |
0.0001 |
| 584 |
HYPERKALAEMIA |
2 |
0.0001 |
| 585 |
METASTASES TO LIVER |
1 |
0.0001 |
| 586 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 587 |
DRUG ERUPTION |
1 |
0.0001 |
| 588 |
OFF LABEL USE |
49 |
0.0001 |
| 589 |
OEDEMA |
3 |
0.0001 |
| 590 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 591 |
TOOTHACHE |
1 |
0.0001 |
| 592 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 593 |
TREMOR |
9 |
0.0001 |
| 594 |
FALL |
18 |
0.0001 |
| 595 |
BRONCHITIS |
4 |
0.0001 |
| 596 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 597 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 598 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 599 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 600 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 601 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 602 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 603 |
FOOT FRACTURE |
1 |
0.0001 |
| 604 |
CONDITION AGGRAVATED |
16 |
0.0001 |
| 605 |
ACUTE KIDNEY INJURY |
8 |
0.0001 |
| 606 |
ORAL HERPES |
1 |
0.0001 |
| 607 |
KIDNEY INFECTION |
1 |
0.0001 |
| 608 |
SINUS DISORDER |
1 |
0.0001 |
| 609 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 610 |
WEIGHT DECREASED |
14 |
0.0001 |
| 611 |
CONFUSIONAL STATE |
8 |
0.0000 |
| 612 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 613 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 614 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 615 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 616 |
RIB FRACTURE |
1 |
0.0000 |
| 617 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 618 |
DERMATITIS |
1 |
0.0000 |
| 619 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 620 |
MYALGIA |
8 |
0.0000 |
| 621 |
EATING DISORDER |
1 |
0.0000 |
| 622 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 623 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 624 |
SKIN CANCER |
1 |
0.0000 |
| 625 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 626 |
AMNESIA |
3 |
0.0000 |
| 627 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 628 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 629 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 630 |
INJECTION SITE PRURITUS |
3 |
0.0000 |
| 631 |
RASH PAPULAR |
1 |
0.0000 |
| 632 |
NASOPHARYNGITIS |
8 |
0.0000 |
| 633 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 634 |
SEIZURE |
5 |
0.0000 |
| 635 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 636 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 637 |
RENAL DISORDER |
2 |
0.0000 |
| 638 |
ARRHYTHMIA |
2 |
0.0000 |
| 639 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 640 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 641 |
MOBILITY DECREASED |
3 |
0.0000 |
| 642 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 643 |
LOCALISED INFECTION |
1 |
0.0000 |
| 644 |
CONSTIPATION |
9 |
0.0000 |
| 645 |
NEURALGIA |
1 |
0.0000 |
| 646 |
MALAISE |
18 |
0.0000 |
| 647 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 648 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 649 |
LIVER INJURY |
1 |
0.0000 |
| 650 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 651 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 652 |
EPISTAXIS |
3 |
0.0000 |
| 653 |
HYPOAESTHESIA |
6 |
0.0000 |
| 654 |
SOMNOLENCE |
8 |
0.0000 |
| 655 |
HAEMATEMESIS |
1 |
0.0000 |
| 656 |
FLUID RETENTION |
2 |
0.0000 |
| 657 |
ERYTHEMA |
8 |
0.0000 |
| 658 |
ILLNESS |
4 |
0.0000 |
| 659 |
INFLAMMATION |
2 |
0.0000 |
| 660 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 661 |
HAEMATOMA |
1 |
0.0000 |
| 662 |
DIPLOPIA |
1 |
0.0000 |
| 663 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 664 |
JAUNDICE |
1 |
0.0000 |
| 665 |
CARDIAC ARREST |
3 |
0.0000 |
| 666 |
BLISTER |
2 |
0.0000 |
| 667 |
HYPONATRAEMIA |
2 |
0.0000 |
| 668 |
PAIN IN JAW |
1 |
0.0000 |
| 669 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 670 |
LETHARGY |
2 |
0.0000 |
| 671 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 672 |
DYSPHONIA |
2 |
0.0000 |
| 673 |
PAIN |
21 |
0.0000 |
| 674 |
ASCITES |
1 |
0.0000 |
| 675 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 676 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 677 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 678 |
CATARACT |
2 |
0.0000 |
| 679 |
APHASIA |
1 |
0.0000 |
| 680 |
STOMATITIS |
2 |
0.0000 |
| 681 |
VERTIGO |
2 |
0.0000 |
| 682 |
EPILEPSY |
1 |
0.0000 |
| 683 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 684 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 685 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 686 |
CHOLELITHIASIS |
1 |
0.0000 |
| 687 |
EYE DISORDER |
1 |
0.0000 |
| 688 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 689 |
URINARY RETENTION |
1 |
0.0000 |
| 690 |
EYE PRURITUS |
1 |
0.0000 |
| 691 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 692 |
HAEMATURIA |
1 |
0.0000 |
| 693 |
NAUSEA |
23 |
0.0000 |
| 694 |
RASH MACULAR |
1 |
0.0000 |
| 695 |
PAIN IN EXTREMITY |
8 |
0.0000 |
| 696 |
DYSGEUSIA |
2 |
0.0000 |
| 697 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 698 |
DYSARTHRIA |
1 |
0.0000 |
| 699 |
HALLUCINATION |
2 |
0.0000 |
| 700 |
PRURITUS |
10 |
0.0000 |
| 701 |
DISEASE PROGRESSION |
3 |
0.0000 |
| 702 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 703 |
THROMBOSIS |
2 |
0.0000 |
| 704 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 705 |
ARTHRALGIA |
10 |
0.0000 |
| 706 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 707 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 708 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 709 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 710 |
SKIN IRRITATION |
1 |
0.0000 |
| 711 |
TINNITUS |
1 |
0.0000 |
| 712 |
SWELLING |
2 |
0.0000 |
| 713 |
VOMITING |
10 |
0.0000 |
| 714 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 715 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 716 |
HEADACHE |
13 |
0.0000 |
| 717 |
DYSPEPSIA |
2 |
0.0000 |
| 718 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 719 |
DYSPNOEA |
11 |
0.0000 |
| 720 |
ECZEMA |
1 |
0.0000 |
| 721 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 722 |
PARAESTHESIA |
3 |
0.0000 |
| 723 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 724 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 725 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 726 |
MEDICATION ERROR |
1 |
0.0000 |
| 727 |
URTICARIA |
3 |
0.0000 |
| 728 |
EYE PAIN |
1 |
0.0000 |
| 729 |
FLATULENCE |
1 |
0.0000 |
| 730 |
EYE IRRITATION |
1 |
0.0000 |
| 731 |
FEELING HOT |
1 |
0.0000 |
| 732 |
CHEST PAIN |
3 |
0.0000 |
| 733 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 734 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 735 |
DEHYDRATION |
2 |
0.0000 |
| 736 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 737 |
VISION BLURRED |
2 |
0.0000 |
| 738 |
BURNING SENSATION |
1 |
0.0000 |
| 739 |
INJURY |
1 |
0.0000 |
| 740 |
SLEEP DISORDER |
1 |
0.0000 |
| 741 |
HYPERTENSION |
3 |
0.0000 |
| 742 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 743 |
ACNE |
1 |
0.0000 |
| 744 |
DIABETES MELLITUS |
1 |
0.0000 |
| 745 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 746 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 747 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 748 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 749 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 750 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 751 |
FLUSHING |
1 |
0.0000 |
| 752 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 753 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 754 |
ASTHMA |
1 |
0.0000 |
| 755 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 756 |
JOINT SWELLING |
1 |
0.0000 |
| 757 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 758 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 759 |
DRUG INTERACTION |
1 |
0.0000 |
| 760 |
DIZZINESS |
3 |
0.0000 |
| 761 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 762 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 763 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 764 |
MUSCLE SPASMS |
1 |
0.0000 |
| 765 |
ALOPECIA |
1 |
0.0000 |
| 766 |
WEIGHT INCREASED |
1 |
0.0000 |
| 767 |
DEPRESSION |
1 |
0.0000 |
| 768 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 769 |
INSOMNIA |
1 |
0.0000 |
| 770 |
DRUG INEFFECTIVE |
1 |
0.0000 |